Results 131 to 140 of about 48,070 (253)
New therapeutic options for metabolic‐associated steatotic liver disease
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley +1 more source
Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
Serum digoxin-like factor was detected in infants of diabetic mothers who were insulin-dependent or diet controlled. No statistical difference was found between the serum digoxin-like factor levels of the infants of diabetic mothers and the ...
M Yurdakök +3 more
doaj
Primary Systemic Carnitine Deficiency Complicated With Severe Cardiomyopathy: A Case Report
ABSTRACT We report a 6‐year‐2‐month‐old girl with SLC22A5‐related PSCD presenting with severe cardiomyopathy, pneumonia, and anemia. Trio‐WES confirmed the c.338G>A homozygous variant. L‐carnitine replacement, combined with standard heart‐failure therapy, was followed by prominent cardiac recovery, alerting clinicians to suspect PSCD in unexplained ...
Xiaojuan Luo, Jia Luo
wiley +1 more source
In this study we produced and purified a high titer of specific and high affin¬ity Fab fragments of anti-digoxin antibody. Immunization of rabbits with a conju¬gate of the cardiac glycoside digoxin, coupled by a periodate oxidation method to the amino ...
M. Pour-Amir +4 more
doaj
Abstract Clinical pharmacokinetic drug–drug interaction (PK‐DDI) studies are frequently required in drug development when metabolizing enzymes and transporters determine pharmacokinetics. Drugs can be victims, perpetrators, or victims and perpetrators, of PK‐DDIs, so the clinical consequences of these interactions, particularly the risks of severe ...
Thomas M. Polasek, John O. Miners
wiley +1 more source
Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets
ALD imposes a growing global burden influenced by alcohol consumption, genetic susceptibility, and obesity. Its pathogenesis involves interactions among ethanol metabolism, oxidative stress, innate immune activation, regulated cell death, and disruption of the gut–liver axis.
Shuyan Wang, Yirui Hu, Huikuan Chu
wiley +1 more source
Background Recent evidence suggests that providers who continue to use digoxin for induced fetal demise prior to later medication abortion should consider patient preferences in how they offer digoxin and consider tools to ensure patient understanding ...
Abraham Fessehaye Sium +2 more
doaj +1 more source
ABSTRACT Objective To assess the efficacy and safety of transplacental flecainide and/or digoxin for fetal tachyarrhythmias when sotalol is unavailable. Method We evaluated transplacental flecainide, digoxin, or combination therapy in a retrospective and prospective cohort across two Thai tertiary centers.
Mukpradab Darakamas +6 more
wiley +1 more source
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 6, December 2026.
Armin Andersen +7 more
wiley +1 more source
Cervical ectopic pregnancy at 22 weeks: A case with subsequent pregnancy outcome
Abstract Introduction Cervical ectopic pregnancies are rare ectopic pregnancies inherently associated with abnormal placentation. Fertility‐sparing management of cervical ectopic pregnancy can have benefits for the patient, but such treatment strategies are less successful in the second trimester.
Joyce Y. Wang +3 more
wiley +1 more source

